biodel inc (BIOD:NASDAQ CM)
Daniel Lorber M.D., F.A.C.P., C.D.E.
Director, Member of The Scientific Advisory Board, Member of Nominating & Governance Committee and Member of Science & Technology Committee, Biodel Inc.
|Age||Total Calculated Compensation||This person is connected to 15 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Dr. Daniel Lorber, MD, FACP, CDE, has been a Medical Director of Diabetes Control Foundation, Diabetes Care & Information Center in Flushing, NY since 1981. Dr. Lorber serves as an Attending Physician in Endocrinology and General Internal Medicine at the New York Hospital Medical Center of Queens. Dr. Lorber has been a Clinical Associate Professor of Medicine at Weill Medical College of Cornell University since 1994. He serves as a consultant in medical, dental and podiatric ...
100 Saw Mill RoadPhone: 203-796-5000
Danbury, Connecticut 06810
Board Members Memberships*
Director, Member of The Scientific Advisory Board, Member of Nominating & Governance Committee and Member of Science & Technology Committee
Albert Einstein College of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Lars Rebien Sørensen||Chief Executive Officer, President and Member of the Senior Management Board|
Novo Nordisk A/S
|Christopher A. Viehbacher||Chief Executive Officer, Director and Member of Strategy Committee|
|€3.5M||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25